Methods for assessing platelet function

Abstract

The present application relates generally to methods for assessing platelet function, for example in a sample from a subject. These methods can be used to identify subjects based on their platelet reactivity or sensitivity to a platelet activating substance, such as collagen-related peptide (CRP), or a thrombin, ADP, thromboxane A2 or adrenaline receptor agonist. The application also provides methods that involve assessing the level of CD36 in platelets of a subject, the level of GPVI in platelets of the subject, and/or the age of the subject as indicators of the platelet function in that subject. The methods can be used to predict the responsiveness of a subject to anti-platelet therapy and so can form part of a therapeutic method.

Dependencies are inferred from the claim text.